Publications by authors named "Magda N A Nasr"

Claim this Profile
D
Design, synthesis, and biological evaluation of quinazoline-benzohydrazide and quinazoline-benzothiazole hybrids uncovering a dual EGFR/VEGFR-2 inhibitor with pronounced cytotoxic activity against triple-negative breast Cancer.
Noura F M El Hamaky, Abdelrahman Hamdi, Waleed A Bayoumi, Abdullah A Elgazar, Magda N A Nasr

Bioorg Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Novel Tetrahydropyrimidine and Fused Pyrimidine-Based Compounds as DHFR Inhibitors and Antimicrobial Agents: Synthesis, In Vitro, In Vivo, and In Silico Studies.
Menna M Sherif, Basem Mansour, May A El-Antrawy, Heba A Abdelaziz, Sahar M I Badr, Magda N A Nasr

Drug Dev Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin-4-One Derivatives as Dual EGFR and FGFR Inhibitors.
Sara Sultan, Samar S Tawfik, Khalid B Selim, Magda N A Nasr

Drug Dev Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study.
Noura F M El Hamaky, Abdelrahman Hamdi, Waleed A Bayoumi, Abdullah A Elgazar, Magda N A Nasr

Bioorg Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study.
Fiby N Takla, Waleed A Bayoumi, Shahenda M El-Messery, Magda N A Nasr

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity.
Mohamed G Thabit, Amany S Mostafa, Khalid B Selim, Magda A A Elsayed, Magda N A Nasr

Arch Pharm (Weinheim)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors.
Nareman A Nawareg, Amany S Mostafa, Shahenda M El-Messery, Magda N A Nasr

Bioorg Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity.
Mohamed G Thabit, Amany S Mostafa, Khalid B Selim, Magda A A Elsayed, Magda N A Nasr

Bioorg Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors.
Wafaa A Ewes, Mohammad A Elmorsy, Shahenda M El-Messery, Magda N A Nasr

Bioorg Med Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds.
Shaimaa A Morsy, Abdelbasset A Farahat, Magda N A Nasr, Atif S Tantawy

Saudi Pharm J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Said M Bayomi, Hassan A El-Kashef, Mahmoud B El-Ashmawy, Magda N A Nasr, Magda A El-Sherbeny

Eur J Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents.
Magda N A Nasr, Shehta A Said

Arch Pharm (Weinheim)· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
Magda Nasr Ahmed Nasr

Arch Pharm (Weinheim)· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis